Search Results - "EXLEY, Andrew"
-
1
Clinical development of cell therapies for cancer: The regulators' perspective
Published in European journal of cancer (1990) (01-10-2020)“…Novel cell therapies for haematological malignancies and solid tumours address pressing clinical need while offering potentially paradigm shifts in efficacy…”
Get full text
Journal Article -
2
Regulating innovation in the early development of cell therapies
Published in Immunotherapy advances (01-01-2021)“…Clinical need for paradigm shifts in efficacy and safety is driving the rapid and wide-ranging innovation in cell therapies for cancer beyond existing…”
Get full text
Journal Article -
3
Evidence of Dysfunction of Endothelial Progenitors in Pulmonary Arterial Hypertension
Published in American journal of respiratory and critical care medicine (15-10-2009)“…Severe pulmonary arterial hypertension (PAH) is characterized by the formation of plexiform lesions and concentric intimal fibrosis in small pulmonary…”
Get full text
Journal Article -
4
Impaired Natural Killer Cell Phenotype and Function in Idiopathic and Heritable Pulmonary Arterial Hypertension
Published in Circulation (New York, N.Y.) (28-08-2012)“…Beyond their role as innate immune effectors, natural killer (NK) cells are emerging as important regulators of angiogenesis and vascular remodeling. Pulmonary…”
Get full text
Journal Article -
5
Definitions of non-response and response to biological therapy for severe asthma: a systematic review
Published in ERJ open research (2023)“…Biologics have proven efficacy for patients with severe asthma but there is lack of consensus on defining response. We systematically reviewed and appraised…”
Get full text
Journal Article -
6
The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency
Published in The Journal of heart and lung transplantation (01-10-2005)“…Lung transplantation is an established treatment for end-stage bronchiectasis. A proportion of patients with bronchiectasis have an associated antibody…”
Get more information
Journal Article -
7
Streamlined approval of biosimilars: moving on from the confirmatory efficacy trial
Published in Drug discovery today (01-11-2020)“…•Licensing of biosimilars promotes wider patient access to essential medicines.•Currently, regulators require comparative efficacy trials for complex…”
Get full text
Journal Article -
8
Widespread Coronary Inflammation in Unstable Angina
Published in The New England journal of medicine (08-05-2003)“…To the Editor: We share Buffon and colleagues' belief in widespread coronary inflammation (July 4 issue). 1 However, believing in a hypothesis is not the same…”
Get full text
Journal Article -
9
Multi-Parameter Analysis (MPA) of Cells and Serum Using a Standard Flow Cytometer
Published in Clinical immunology (Orlando, Fla.) (01-01-2007)Get full text
Journal Article -
10
480: HIERARCHY OF VALUES IN RECOVERY OF RESPIRATORY FAILURE: PROSPECTIVE STUDY OF PATIENTS AND CAREGIVERS
Published in Critical care medicine (01-01-2022)Get full text
Journal Article -
11
-
12
Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)
Published in The European respiratory journal (01-04-2023)“…Effectiveness studies with biological therapies for asthma lack standardised outcome measures. The COMSA (Core Outcome Measures sets for paediatric and adult…”
Get full text
Journal Article -
13
Recommendations for the Development and Validation of Immunogenicity Assays in Support of Biosimilar Programs
Published in The AAPS journal (01-01-2020)“…For biosimilar drug development programs, it is essential to demonstrate that there are no clinically significant differences between the proposed biosimilar…”
Get full text
Journal Article -
14
Revisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients From 30 Countries
Published in Medicine (Baltimore) (01-11-2010)“…Interleukin-12 receptor β1 (IL-12Rβ1) deficiency is the most common form of Mendelian susceptibility to mycobacterial disease (MSMD). We undertook an…”
Get full text
Journal Article -
15
Revisiting Human IL-12R beta 1 Deficiency A Survey of 141 Patients From 30 Countries
Published in Medicine (Baltimore) (01-11-2010)“…Interleukin-12 receptor beta 1 (IL-12R beta 1) deficiency is the most common form of Mendelian susceptibility to mycobacterial disease (MSMD). We undertook an…”
Get full text
Journal Article -
16
Identifying and appraising outcome measures for severe asthma: a systematic review
Published in The European respiratory journal (01-04-2023)“…Valid outcome measures are imperative to evaluate treatment response, yet the suitability of existing end-points for severe asthma is unclear. This review…”
Get full text
Journal Article -
17
Health Expectations and Quality of Life After Acute Respiratory Failure
Published in Chest (01-07-2023)“…Patients often have high expectations for recovery after critical illness, but the impact of these expectations on subsequent quality of life (QoL) after…”
Get full text
Journal Article -
18
Health Expectations and Quality of Life After Acute Respiratory Failure: A Multicenter Prospective Cohort Study
Published in Chest (01-07-2023)“…Patients often have high expectations for recovery after critical illness, but the impact of these expectations on subsequent quality of life (QoL) after…”
Get full text
Journal Article -
19
2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation
Published in Bioanalysis (01-03-2021)“…The 14 edition of the Workshop on Recent Issues in Bioanalysis (14 WRIB) was held virtually on June 15-29, 2020 with an attendance of over 1000 representatives…”
Get full text
Journal Article -
20
Association between unmet medication needs after hospital discharge and readmission or death among acute respiratory failure survivors: the addressing post-intensive care syndrome (APICS-01) multicenter prospective cohort study
Published in Critical care (London, England) (07-01-2022)“…Survivors of acute respiratory failure (ARF) commonly experience long-lasting physical, cognitive, and/or mental health impairments. Unmet medication needs…”
Get full text
Journal Article